| Year |
Citation |
Score |
| 2020 |
Burgdorf J, Brudzynski S, Moskal J. Using rat ultrasonic vocalization to study the neurobiology of emotion: from basic science to the development of novel therapeutics for affective disorders. Current Opinion in Neurobiology. 60: 192-200. PMID 31958623 DOI: 10.1016/J.Conb.2019.12.008 |
0.32 |
|
| 2019 |
Burgdorf JS, Christian EP, Sørensen L, Stanton PK, Leaderbrand K, Madsen TM, Khan MA, Kroes RA, Moskal JR. A translational EEG-based approach to assess modulation of long-lasting NMDAR-dependent synaptic plasticity. Psychopharmacology. PMID 31392357 DOI: 10.1007/S00213-019-05341-W |
0.304 |
|
| 2019 |
Bowers MS, Cacheaux LP, Sahu SU, Schmidt ME, Sennello JA, Leaderbrand K, Khan MA, Kroes RA, Moskal JR. NYX-2925 induces metabotropic NMDAR signaling that enhances synaptic NMDAR and AMPAR. Journal of Neurochemistry. PMID 31376158 DOI: 10.1111/Jnc.14845 |
0.328 |
|
| 2018 |
Donello JE, Banerjee P, Li YX, Guo YX, Yoshitake T, Zhang XL, Miry O, Kehr J, Stanton PK, Gross AL, Burgdorf JS, Kroes RA, Moskal JR. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-like Effects. The International Journal of Neuropsychopharmacology. PMID 30544218 DOI: 10.1093/Ijnp/Pyy101 |
0.33 |
|
| 2018 |
Ghoreishi-Haack N, Priebe JM, Aguado JD, Colechio EM, Burgdorf JS, Bowers MS, Cearley CN, Khan MA, Moskal JR. NYX-2925 is a novel NNMDA receptor modulator that induces rapid and long-lasting analgesia in rat models of neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics. PMID 29986951 DOI: 10.1124/Jpet.118.249409 |
0.305 |
|
| 2017 |
Khan MA, Houck DR, Gross AL, Zhang XL, Cearley C, Madsen TM, Kroes RA, Stanton PK, Burgdorf J, Moskal JR. NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory. The International Journal of Neuropsychopharmacology. PMID 29099938 DOI: 10.1093/Ijnp/Pyx096 |
0.318 |
|
| 2016 |
Liu RJ, Duman C, Kato T, Hare B, Lopresto D, Bang E, Burgdorf J, Moskal J, Taylor J, Aghajanian G, Duman RS. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27634355 DOI: 10.1038/Npp.2016.202 |
0.313 |
|
| 2016 |
Moskal JR, Burgdorf JS, Stanton PK, Kroes RA, Disterhoft JF, Burch RM, Amin Khan M. The Development of Rapastinel (Formerly GLYX-13); a rapid acting and long lasting antidepressant. Current Neuropharmacology. PMID 26997507 DOI: 10.2174/1570159X14666160321122703 |
0.343 |
|
| 2015 |
Burgdorf J, Zhang XL, Weiss C, Gross A, Boikess SR, Kroes RA, Khan MA, Burch RM, Rex CS, Disterhoft JF, Stanton PK, Moskal JR. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus. Neuroscience. 308: 202-211. PMID 26343295 DOI: 10.1016/J.Neuroscience.2015.09.004 |
0.327 |
|
| 2015 |
Zhang XL, Shuttleworth CW, Moskal JR, Stanton PK. Suppression of spreading depolarization and stabilization of dendritic spines by GLYX-13, an NMDA receptor glycine-site functional partial agonist. Experimental Neurology. 273: 312-321. PMID 26244282 DOI: 10.1016/J.Expneurol.2015.07.025 |
0.344 |
|
| 2015 |
Burgdorf J, Kroes RA, Zhang XL, Gross AL, Schmidt M, Weiss C, Disterhoft JF, Burch RM, Stanton PK, Moskal JR. Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats. Behavioural Brain Research. 294: 177-85. PMID 26210936 DOI: 10.1016/J.Bbr.2015.07.039 |
0.317 |
|
| 2015 |
Wildburger NC, Zhou S, Zacharias LG, Kroes RA, Moskal JR, Schmidt M, Mirzaei P, Gumin J, Lang FF, Mechref Y, Nilsson CL. Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts. Journal of Proteome Research. 14: 3932-9. PMID 26185906 DOI: 10.1021/Acs.Jproteome.5B00549 |
0.305 |
|
| 2015 |
Preskorn S, Macaluso M, Mehra DO, Zammit G, Moskal JR, Burch RM. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. Journal of Psychiatric Practice. 21: 140-9. PMID 25782764 DOI: 10.1097/01.Pra.0000462606.17725.93 |
0.305 |
|
| 2015 |
Basu S, Ma R, Moskal JR, Basu M. Regulations of glycolipid: XI. glycosyltransferase (GSL: GLTs) genes involved in SA-LeX and related GSLs biosynthesis in carcinoma cells by Biosimilar apoptotic agents: potential anticancer drugs. Advances in Experimental Medicine and Biology. 842: 329-54. PMID 25408353 DOI: 10.1007/978-3-319-11280-0_21 |
0.313 |
|
| 2014 |
Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF, Leander JD. GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opinion On Investigational Drugs. 23: 243-54. PMID 24251380 DOI: 10.1517/13543784.2014.852536 |
0.349 |
|
| 2014 |
Nilsson CL, Wildburger NC, Gumin J, Kroes RA, Moskal JR, Mechref Y, Lang FF. SC-24 * IMPROVEMENT OF HUMAN MESENCHYMAL STEM CELL HOMING IN DELIVERY OF THERAPEUTIC AGENTS TO GLIOMA STEM CELL XENOGRAFTS Neuro-Oncology. 16: v202-v202. DOI: 10.1093/Neuonc/Nou275.24 |
0.311 |
|
| 2013 |
Burgdorf J, Moskal JR, Brudzynski SM, Panksepp J. Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors. Behavioural Brain Research. 251: 18-24. PMID 23623884 DOI: 10.1016/J.Bbr.2013.04.022 |
0.33 |
|
| 2013 |
Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 729-42. PMID 23303054 DOI: 10.1038/Npp.2012.246 |
0.37 |
|
| 2013 |
Burgdorf J, Zhang XL, Nicholson KL, Balster RL, Leander JD, Stanton PK, Gross AL, Kroes RA, Moskal JR. Erratum: GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects (Neuropsychopharmacology (2013) 37 (1374) DOI: 10.1038/npp.2013.42) Neuropsychopharmacology. 38. DOI: 10.1038/Npp.2013.42 |
0.305 |
|
| 2012 |
Basu S, Ma R, Moskal JR, Basu M. Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses. Neurochemical Research. 37: 1245-55. PMID 22488330 DOI: 10.1007/S11064-012-0762-9 |
0.309 |
|
| 2011 |
Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J. A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neuroscience and Biobehavioral Reviews. 35: 1982-8. PMID 21718719 DOI: 10.1016/J.Neubiorev.2011.06.006 |
0.338 |
|
| 2011 |
Corcoran ME, Kroes RA, Burgdorf JS, Moskal JR. Regional changes in gene expression after limbic kindling. Cellular and Molecular Neurobiology. 31: 819-34. PMID 21424270 DOI: 10.1007/S10571-011-9672-7 |
0.477 |
|
| 2010 |
Kroes RA, He H, Emmett MR, Nilsson CL, Leach FE, Amster IJ, Marshall AG, Moskal JR. Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo. Proceedings of the National Academy of Sciences of the United States of America. 107: 12646-51. PMID 20616019 DOI: 10.1073/Pnas.0909862107 |
0.327 |
|
| 2010 |
Burgdorf J, Kroes RA, Beinfeld MC, Panksepp J, Moskal JR. Uncovering the molecular basis of positive affect using rough-and-tumble play in rats: a role for insulin-like growth factor I. Neuroscience. 168: 769-77. PMID 20350589 DOI: 10.1016/J.Neuroscience.2010.03.045 |
0.312 |
|
| 2010 |
He H, Nilsson CL, Emmett MR, Marshall AG, Kroes RA, Moskal JR, Ji Y, Colman H, Priebe W, Lang FF, Conrad CA. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. Journal of Proteome Research. 9: 2098-108. PMID 20199106 DOI: 10.1021/Pr900793A |
0.321 |
|
| 2010 |
He H, Nilsson CL, Emmett MR, Ji Y, Marshall AG, Kroes RA, Moskal JR, Colman H, Lang FF, Conrad CA. Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan. Glycoconjugate Journal. 27: 27-38. PMID 19557511 DOI: 10.1007/S10719-009-9249-6 |
0.312 |
|
| 2009 |
Moskal JR, Kroes RA, Dawson G. The glycobiology of brain tumors: disease relevance and therapeutic potential. Expert Review of Neurotherapeutics. 9: 1529-45. PMID 19831842 DOI: 10.1586/Ern.09.105 |
0.323 |
|
| 2009 |
Stanton PK, Potter PE, Aguilar J, Decandia M, Moskal JR. Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Neuroreport. 20: 1193-7. PMID 19623090 DOI: 10.1097/Wnr.0B013E32832F5130 |
0.309 |
|
| 2009 |
Burgdorf J, Panksepp J, Brudzynski SM, Beinfeld MC, Cromwell HC, Kroes RA, Moskal JR. The effects of selective breeding for differential rates of 50-kHz ultrasonic vocalizations on emotional behavior in rats. Developmental Psychobiology. 51: 34-46. PMID 18819097 DOI: 10.1002/Dev.20343 |
0.311 |
|
| 2008 |
Zhang XL, Sullivan JA, Moskal JR, Stanton PK. A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus. Neuropharmacology. 55: 1238-50. PMID 18796308 DOI: 10.1016/J.Neuropharm.2008.08.018 |
0.321 |
|
| 2008 |
Wood PL, Mahmood SA, Moskal JR. Antinociceptive action of GLYX-13: an N-methyl-D-aspartate receptor glycine site partial agonist. Neuroreport. 19: 1059-61. PMID 18580579 DOI: 10.1097/Wnr.0B013E32830435C9 |
0.315 |
|
| 2007 |
Kroes RA, Dawson G, Moskal JR. Focused microarray analysis of glyco-gene expression in human glioblastomas. Journal of Neurochemistry. 103: 14-24. PMID 17986135 DOI: 10.1111/J.1471-4159.2007.04780.X |
0.308 |
|
| 2007 |
Wood PL, Khan MA, Moskal JR. Cellular thiol pools are responsible for sequestration of cytotoxic reactive aldehydes: central role of free cysteine and cysteamine. Brain Research. 1158: 158-63. PMID 17555724 DOI: 10.1016/J.Brainres.2007.05.007 |
0.31 |
|
| 2007 |
Kroes RA, Burgdorf J, Otto NJ, Panksepp J, Moskal JR. Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray. Behavioural Brain Research. 182: 290-300. PMID 17452055 DOI: 10.1016/J.Bbr.2007.03.022 |
0.328 |
|
| 2006 |
Wood PL, Khan MA, Kulow SR, Mahmood SA, Moskal JR. Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines. Brain Research. 1095: 190-9. PMID 16730673 DOI: 10.1016/J.Brainres.2006.04.038 |
0.312 |
|
| 2006 |
Kroes RA, Panksepp J, Burgdorf J, Otto NJ, Moskal JR. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience. 137: 37-49. PMID 16289586 DOI: 10.1016/J.Neuroscience.2005.08.076 |
0.309 |
|
| 2006 |
Burgdorf J, Panksepp J, Beinfeld MC, Kroes RA, Moskal JR. Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats. Peptides. 27: 172-7. PMID 16143427 DOI: 10.1016/J.Peptides.2005.07.005 |
0.304 |
|
| 2005 |
Moskal JR, Kuo AG, Weiss C, Wood PL, O'Connor Hanson A, Kelso S, Harris RB, Disterhoft JF. GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator. Neuropharmacology. 49: 1077-87. PMID 16051282 DOI: 10.1016/J.Neuropharm.2005.06.006 |
0.358 |
|
| 2004 |
Panksepp J, Burgdorf J, Beinfeld MC, Kroes RA, Moskal JR. Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats. Brain Research. 1025: 75-84. PMID 15464747 DOI: 10.1016/J.Brainres.2004.07.076 |
0.318 |
|
| 2004 |
Dawson G, Moskal JR, Dawson SA. Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death. Journal of Neurochemistry. 89: 1436-44. PMID 15189346 DOI: 10.1111/J.1471-4159.2004.02435.X |
0.304 |
|
| 2001 |
Moskal JR, Yamamoto H, Colley PA. The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors. Current Drug Targets. 2: 331-45. PMID 11554557 DOI: 10.2174/1389450013348399 |
0.304 |
|
| 2000 |
Kroes RA, Jastrow A, McLone MG, Yamamoto H, Colley P, Kersey DS, Yong VW, Mkrdichian E, Cerullo L, Leestma J, Moskal JR. The identification of novel therapeutic targets for the treatment of malignant brain tumors Cancer Letters. 156: 191-198. PMID 10880769 DOI: 10.1016/S0304-3835(00)00462-6 |
0.31 |
|
| 1997 |
Yamamoto H, Kaneko Y, Rebbaa A, Bremer EG, Moskal JR. α2,6-sialyltransferase gene transfection into a human glioma cell line (U373 MG) results in decreased invasivity Journal of Neurochemistry. 68: 2566-2576. PMID 9166754 DOI: 10.1046/J.1471-4159.1997.68062566.X |
0.32 |
|
| 1997 |
Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, Bremer EG, Taniguchi N, Moskal JR. Gene transfection-mediated overexpression of β1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function Journal of Biological Chemistry. 272: 9275-9279. PMID 9083062 DOI: 10.1074/Jbc.272.14.9275 |
0.325 |
|
| 1996 |
Rebbaa A, Yamamoto H, Moskal JR, Bremer EG. Binding of erythroagglutinating phytohemagglutinin lectin from Phaseolus vulgaris to the epidermal growth factor receptor inhibits receptor function in the human glioma cell line, U373 MG Journal of Neurochemistry. 67: 2265-2272. PMID 8931457 DOI: 10.1046/J.1471-4159.1996.67062265.X |
0.315 |
|
| 1994 |
Boehm FH, Liem LK, Stanton PK, Potter PE, Moskal JR. Phenytoin protects against hypoxia-induced death of cultured hippocampal neurons. Neuroscience Letters. 175: 171-4. PMID 7970203 DOI: 10.1016/0304-3940(94)91106-1 |
0.304 |
|
| 1992 |
Thompson LT, Moskal JR, Disterhoft JF. Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine. Nature. 359: 638-41. PMID 1406995 DOI: 10.1038/359638A0 |
0.334 |
|
| 1991 |
Haring R, Stanton PK, Scheideler MA, Moskal JR. Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation. Journal of Neurochemistry. 57: 323-32. PMID 1828831 DOI: 10.1111/J.1471-4159.1991.Tb02131.X |
0.3 |
|
| 1990 |
Maleci A, Alterman RL, Sundstrom D, Kornblith PL, Moskal JR. Effect of phorbol esters on the susceptibility of a glioma cell line to lymphokine-activated killer cell activity Journal of Neurosurgery. 73: 91-97. PMID 2352027 DOI: 10.3171/Jns.1990.73.1.0091 |
0.32 |
|
| 1986 |
Moskal JR, Schaffner AE. Monoclonal antibodies to the dentate gyrus: Immunocytochemical characterization and flow cytometric analysis of hippocampal neurons bearing a unique cell-surface antigen Journal of Neuroscience. 6: 2045-2053. PMID 3734875 DOI: 10.1523/Jneurosci.06-07-02045.1986 |
0.328 |
|
| 1985 |
Pruss RM, Moskal JR, Eiden LE, Beinfeld MC. Specific regulation of vasoactive intestinal polypeptide biosynthesis by phorbol ester in bovine chromaffin cells Endocrinology. 117: 1020-1026. PMID 3839453 DOI: 10.1210/Endo-117-3-1020 |
0.314 |
|
| 1981 |
Warren ST, Yotti LP, Moskal JR, Chang CC, Trosko JE. Metabolic cooperation in CHO and V79 cells following treatment with a tumor promoter Experimental Cell Research. 131: 427-430. PMID 7202544 DOI: 10.1016/0014-4827(81)90250-0 |
0.306 |
|
| 1978 |
Macher BA, Lockney M, Moskal JR, Fung YK, Sweeley CC. Studies on the mechanism of butyrate-induced morphological changes in KB cells Experimental Cell Research. 117: 95-102. PMID 720409 DOI: 10.1016/0014-4827(78)90431-7 |
0.307 |
|
| 1974 |
Moskal JR, Gardner DA, Basu S. Changes in glycolipid glycosyltransferases and glutamate decarboxylase and their relationship to differentiation in neuroblastoma cells Biochemical and Biophysical Research Communications. 61: 751-758. PMID 4375999 DOI: 10.1016/0006-291X(74)91021-3 |
0.313 |
|
| Show low-probability matches. |